You just read:

Intarcia Submits New Drug Application (NDA) to FDA for U.S. Marketing Approval of ITCA 650 in Type 2 Diabetes

News provided by

Intarcia Therapeutics, Inc.

Nov 21, 2016, 08:30 ET